Search

everythinglearnresearchcommunity

for

Search:↓

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Lower SHBG levels may increase the risk of PCOS.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Chronic stress can cause hair loss by increasing oxidative stress, but antioxidants may help.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Some breast cancer chemotherapy can cause permanent hair loss.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

No cure for female pattern hair loss, but various effective treatments exist.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The hair follicle pathway significantly affects how easily water-loving chemicals pass through the skin.